VSIG2 抗体 (C-Term)
Quick Overview for VSIG2 抗体 (C-Term) (ABIN1881996)
抗原
See all VSIG2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
- 
    - 
                                            抗原表位
- AA 250-278, C-Term
- 
                                            纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- 
                                            免疫原
- This VSIG2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 250-278 amino acids from the C-terminal region of human VSIG2.
- 
                                            亚型
- Ig Fraction
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- WB: 1:1000. WB: 1:1000
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C,-20 °C
- 
                                            有效期
- 6 months
 
- 
                                            
- 
    - 
                                            : "CTX, a Xenopus thymocyte receptor, defines a molecular family conserved throughout vertebrates."    in: European journal of immunology, Vol. 28, Issue 12, pp. 4094-104, (1999)         (PubMed).        
 
 
- 
                                            : "CTX, a Xenopus thymocyte receptor, defines a molecular family conserved throughout vertebrates."    in: European journal of immunology, Vol. 28, Issue 12, pp. 4094-104, (1999)         (PubMed).        
- 
    
- 
                    
 
                                     
                                     
                                    